RNLX: Gunggung utang perusahaan Renalytix Plc

Simbol lan logo merek Renalytix Plc (RNLX)

The market trend for the share price of Renalytix Plc (RNLX), which specializes in renal pathology therapy, demonstrates a value of 0.00. The business's moat is based on proprietary AI algorithms and integration into insurance systems. Reliability is ensured by redundant servers and a network of laboratories in the UK and US. Due to its independence from the global economy and the perennial demand for healthcare, Renalytix Plc (RNLX) serves as a resilient defensive asset.

RNLX: Utang perusahaan Renalytix PLC 04.07.2022 - 19.10.2024

Renalytix, plc (RNLX) - rincian metrik lan laporan keuangan

- rega saham lan konsensus proyeksi valuasi:
Bagan owah-owahan rega Renalytix PLC|RNLX - Prakiraan konsensus analis
- informasi kapitalisasi pasar:
Kapitalisasi pasar Renalytix AI|RNLX - Nilai Total Perusahaan
- data ekuitas miturut neraca:
Nilai Akuntansi Saham Renalytix|RNLX - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Aset Bersih renalytix.com|RNLX - Total Aset Perusahaan
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Renalytix Plc|RNLX - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Renalytix Plc|RNLX - Utang perusahaan|Utang-utang marang kapitalisasi buku Renalytix AI|RNLX - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Renalytix|Rasio likuiditas darurat renalytix.com
- informasi bathi lan kelipatan valuasi:
RNLX - Bathi resik perusahaan
Analisis fundamental perusahaan:RNLX Renalytix
Produk mawa merek Renalytix, plc

To assess the long-term reliability of Renalytix Plc (RNLX), debt dynamics reflecting the ratio of total liabilities to current market capitalization are critical. An increase in this metric signals growing financial leverage, which, combined with the macro-resilience of the defensive AI kidney diagnostics sector, allows Renalytix Plc (RNLX) to scale effectively without risking stability during economic downturns.

Perusahaan pesaing

TVTX (Travere Corp) - Kewajiban utang agregat|Gunggung utang perusahaan ARDX (Ardelyx, Inc.)|Gunggung utang perusahaan prokidney.com PROK|AKBA - Utang perusahaan|Kewajiban utang agregat TVRD (Cara Therapeutics, Inc.)|DiaMedica Pharma (DMAC) - Utang perusahaan|Gunggung utang perusahaan Unicycive Therapeutics, Inc|RMTI (Rockwell Medical) - Gunggung utang perusahaan|Gunggung utang perusahaan cadrenal.com|Gunggung utang perusahaan CDT (Conduit Pharmaceuticals Inc.)|CALT (calliditas.se) - Kewajiban utang agregat|Utang perusahaan ZyVersa Therapeutics, Inc. ZVSA